AUT00201 aids muscle strength, coordination in ALS mouse model

AUT00201 aids muscle strength, coordination in ALS mouse model

AUT00201, an experimental oral small molecule being developed by Autifony Therapeutics, reduced the loss of motor neurons — the nerve cells that control movement — and eased motor symptoms in a mouse model of amyotrophic lateral sclerosis (ALS), a new study showed. It was also found to improve muscle strength and coordination. The company has completed Phase 1a clinical testing (NCT04158453) of AUT00201 in healthy adults, where both single and m…